Stefan Heytens
- Urology top 2%
- Urinary Bladder and Prostate Research 8
- Clinical Biochemistry top 5%
- Epidemiology top 10%
- Urinary Tract Infections Management 11
- Rheumatology top 5%
- Pelvic floor disorders treatments 8
-
- SARS-CoV-2 and COVID-19 Research 14
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 detection and testing 6
-
- COVID-19 epidemiological studies 7
-
- Vaccine Coverage and Hesitancy 5
- Co-authors
- Gerda VerschraegenMarc De MeyereWim PeersmanJan M. De MaeseneerAn De SutterThierry ChristiaensGeert ClaeysJerina Boelens
- Partner nations
- BelgiumUnited KingdomNetherlands
In The Last Decade
Stefan Heytens
40 papers receiving 585 citations
Peers
Comparison fields: 5 of 75
- Urology 176
- Applied Microbiology and Biotechnology 38
- Clinical Biochemistry 84
- Epidemiology 426
- Rheumatology 168
Countries citing papers authored by Stefan Heytens
This map shows the geographic impact of Stefan Heytens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Heytens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Heytens more than expected).
Fields of papers citing papers by Stefan Heytens
This network shows the impact of papers produced by Stefan Heytens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Heytens. The network helps show where Stefan Heytens may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Stefan Heytens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 5 | |
| 7 | 2022 | 12 | |
| 8 | 2022 | 6 | |
| 9 | 2022 | 20 | |
| 10 | 2022 | 6 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 2 | |
| 13 | 2022 | 3 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 8 | |
| 17 | 2020 | 6 | |
| 18 | Richtlijn cystitis bij de vrouw : herziening 2016 | 2016 | 2 |
| 19 | 2014 | 1 | |
| 20 | De behandeling van CVS in de eerste lijn: uitdaging of verplicht nummer? | 2010 | 1 |
About Stefan Heytens
Stefan Heytens is a scholar working on Modeling and Simulation, Urology and Applied Microbiology and Biotechnology, having authored 47 papers that have together received 605 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (14 papers), Urinary Tract Infections Management (11 papers), Pelvic floor disorders treatments (8 papers), COVID-19 Clinical Research Studies (8 papers), Urinary Bladder and Prostate Research (8 papers), COVID-19 epidemiological studies (7 papers), SARS-CoV-2 detection and testing (6 papers) and Vaccine Coverage and Hesitancy (5 papers). The work is most often cited by research in Urology (176 citations), Applied Microbiology and Biotechnology (38 citations) and Clinical Biochemistry (84 citations). Stefan Heytens has collaborated with scholars based in Belgium, United Kingdom and Netherlands. Frequent co-authors include Gerda Verschraegen, Marc De Meyere, Wim Peersman, Jan M. De Maeseneer, An De Sutter, Thierry Christiaens, Geert Claeys, Jerina Boelens, Liselotte Coorevits and Piet Cools. Their work appears in journals such as The Lancet, PLoS ONE and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.